Organ donor optimisation in the United Kingdom

Abstract

Organ donor optimisation remains a cornerstone in addressing the imbalance between organ supply and demand in the United Kingdom. This narrative review explores the legal, organisational, and clinical frameworks that underpin donor optimisation, outlines key interventions in donor management, and examines recent innovations aimed at improving donor organ yield and equity. We highlight the impact of legislative reforms including the adoption of the soft opt-out system, national strategies coordinated by NHS Blood and Transplant (NHSBT), clinical protocols for brain-dead and circulatory-death donors, and future directions in technological integration and equitable matching. The UK model provides a multifaceted, evolving paradigm in organ donation, balancing clinical rigour, ethical sensitivity, and system-level coherence.